劲风生物

Biotech/Healthcare

Jinfeng Biology focuses on rapidly advancing the R&D and clinical application of tumor cell therapy products. Based on genomics and proteomics, it has broken through bottlenecks in liquid biopsy and single-cell sequencing technologies for tumors.

Latest round: Series A (2021)